Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1CNS 1

Conditions

Pancreatic Neoplasms 14Colorectal Neoplasms 13Rectal Neoplasms 5Colonic Neoplasms 4Adenocarcinoma 4Liver Neoplasms 3Carcinoma, Hepatocellular 3Breast Neoplasms 3Neoplasm Metastasis 2Melanoma 2Esophageal Neoplasms 2Barrett Esophagus 2Adenocarcinoma Of Esophagus 2Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Resectable Pancreatic Ductal Adenocarcinoma 1Prostatic Neoplasms 1Pancreatic Adenocarcinoma 1Ovarian Neoplasms 1Obesity 1Non-DM Stage II High-risk Colorectal Cancer 1Neoplasms 1Motor Activity 1Lymphatic Metastasis 1Lung Neoplasms 1Kidney Neoplasms 1Insulin Resistance 1Hepatitis C, Chronic 1Glioma 1

Interventions

Gemcitabine 113Cisplatin 77Oxaliplatin 46pembrolizumab 35Fluorouracil 33Capecitabine 31durvalumab 27Leucovorin 27lenvatinib 26Magnetic Resonance Spectroscopy 15Irinotecan 14Drug Therapy 13Biopsy 13Nivolumab 12Albumin-Bound Paclitaxel 12tislelizumab 11Specimen Handling 11Radiofrequency Ablation 11130-nm albumin-bound paclitaxel 11pemigatinib 10apatinib 10Taxes 10Radiotherapy 10Floxuridine 10Folfox protocol 9Bevacizumab 9S 1 (combination) 8Platinum 8Photochemotherapy 8Liver Transplantation 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cholangiocarcinoma × Metformin × Gastrointestinal × Clear all
NCT02496741 2020-01-09

MACIST

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 1/2 Completed
15 enrolled
CNSGastrointestinalSarcoma

Chondrosarcoma, Glioma, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡